Virtus LifeSci Valuation Overview

BBC -- USA Etf  

USD 29.18  0.38  1.29%

Virtus LifeSci Biotech has current Real Value of $29.87 per share. The regular price of the etf is $29.18. At this time the etf appears to be under valued. Macroaxis measures value of Virtus LifeSci Biotech from inspecting the etf fundamentals such as Number of Employees of 347, Net Asset of 51.98M and Price to Earning of 39.87times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
Horizon     30 Days    Login   to change
Virtus LifeSci Biotech Clinical Trls ETF is the top ETF in price to earning as compared to similar ETFs. It is fourth largest ETF in three year return as compared to similar ETFs reporting about  0.13  of Three Year Return per Price to Earning. The ratio of Price to Earning to Three Year Return for Virtus LifeSci Biotech Clinical Trls ETF is roughly  7.58 

Current Market Valuation

Virtus LifeSci Biotech Valuation Boundaries

Under Valued
October 17, 2018
29.18
Market Value
29.87
Real Value
Target Odds
  
35.72
Upside
Virtus LifeSci is not too volatile asset. Calculation of real value of Virtus LifeSci Biotech is based on 1 month time horizon. Increasing Virtus LifeSci Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.
Search macroaxis.com